Cargando…
Lack of evidence of seronegative infection in an endemic area of Chagas disease
The diagnosis of Chagas disease is based on the detection of Trypanosoma cruzi (T. cruzi)-specific antibodies. Nonetheless, there is concern about the sensitivity of current serological assays due to reports of T. cruzi PCR positivity among seronegative individuals. The aim of this study was to eval...
Autores principales: | de Oliveira, Léa Campos, Lee, Tzong-Hae, Ferreira, Ariela Mota, Bierrenbach, Ana Luiza, de Souza-Basqueira, Marcela, Oliveira, Cláudia Di Lorenzo, Cardoso, Clareci Silva, Moreira, Carlos Henrique Valente, Oikawa, Marcio K., Ribeiro, Antonio Luiz P., Busch, Michael P, Sabino, Ester Cerdeira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto de Medicina Tropical
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376933/ https://www.ncbi.nlm.nih.gov/pubmed/30785565 http://dx.doi.org/10.1590/S1678-9946201961011 |
Ejemplares similares
-
Benznidazole Use among Patients with Chronic Chagas' Cardiomyopathy in an Endemic Region of Brazil
por: Ferreira, Ariela Mota, et al.
Publicado: (2016) -
Accuracy and reliability of focused echocardiography in patients with Chagas disease from endemic areas: SaMi-Trop cohort study
por: Martins Barros, Isabella Morais, et al.
Publicado: (2021) -
Beneficial effects of benznidazole in Chagas disease: NIH SaMi-Trop cohort study
por: Cardoso, Clareci Silva, et al.
Publicado: (2018) -
Risk Score for Predicting 2‐Year Mortality in Patients With Chagas Cardiomyopathy From Endemic Areas: SaMi‐Trop Cohort Study
por: Di Lorenzo Oliveira, Claudia, et al.
Publicado: (2020) -
Evaluation of the properties of WHODAS-12 measurements in individuals with Chagas disease in Brazil
por: Tavares, Patrícia Aparecida, et al.
Publicado: (2023)